Preclinical studies in rodents have identified a potential signal for thyroid C-cell tumours with GLP-1 receptor agonists
Secher, Jelsing, Baqueror)
With their proven effectiveness and safety, GLP-1 receptor agonists (GLP-1 RAs) have become the leading weight-loss medications worldwide, prompting the pharmaceutical industry to ramp up research and development efforts in this area
Together, they deliver a targeted approach to satiety, balance, and healthy weight management. Clinically studied DNF-10 satiety peptides combine with Pomella pomegranate polyphenols and Akkermansia to help reduce cravings, prolong fullness, and regulate appetite
Genetic Predispositions and Metabolic Response to Weight Management Strategies The PlexusDx Precision Peptide Genetic Test analyzes GLP1R, GIPR, FTO, and MC4R variants that relate to GLP-1 and related signaling pathways
Take two capsules daily, ideally before a meal